Status:
UNKNOWN
Organoid Based Response Prediction in Esophageal Cancer
Lead Sponsor:
University Medical Center Groningen
Conditions:
Organoid
Esophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: Current standard treatment of localized esophageal cancer (EC) with neoadjuvant chemoradiotherapy (nCRT) followed by esophagectomy with curative intent results in 30% complete, 40-60% parti...
Eligibility Criteria
Inclusion
- Histologically proven adeno- or squamous cell carcinoma of the esophagus
- Age ≥ 18 years
- Candidates for curative treatment; clinical stage T1N+/T2-4aN0-3M0
- Scheduled for endoscopic ultrasound (EUS) procedure for staging and/or treatment purposes
- Written informed consent
Exclusion
- Patients who are medically unfit for a curative treatment
- Signs of distant metastases (M1)
- Patients who are mentally disabled or incapable to give informed consent
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03283527
Start Date
December 1 2017
End Date
December 31 2023
Last Update
September 28 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen (UMCG)
Groningen, Netherlands, 9713GZ
2
Martini Ziekenhuis
Groningen, Netherlands, 9728NT
3
Medisch Centrum Leeuwarden
Leeuwarden, Netherlands, 8901BR